Back to Agenda
Closing Remarks
Session Chair(s)
Megan Doyle, JD, MPH
Global Policy Lead, Digital Health, Diagnostics, Oncology
Amgen, United States
Shyreen Kamal, PharmD
Manager, Scientific Programs
DIA, United States
Closing Remarks
Have an account?